Cancer Supportive Care Products Market: Unmet Medical Needs in Emerging Economies Present Host of Opportunities

Cancer incidence and mortality rate has risen alarmingly over the past few years, as observed by leading health and cancer organizations. This surge has resulted in the development of a wide range of drugs and treatment options to prevent the side-effects of radiation and chemotherapy, thereby boosting the demand for cancer supportive care products. Persistence Market Research (PMR) predicts that the global market for cancer supportive care products will expand at 4.30% CAGR from 2015 to 2021.

Read Full Report:

Cancer Numbers on the Rise

The National Cancer Institute in the U.S. estimates that by the end of 2015, there will be 1,658,370 new cases of cancer and 589,430 cancer-related deaths in the country. Last year, 15,780 adolescents and children between the age of 0 and 19 were diagnosed with cancer in the U.S., with 1,960 of them dying from the disease. An estimated 39.60% women and men in the country will be diagnosed with the deadly disease at some point in their life, with the yearly rate of cancer incidence among men and women being 454.8 per 100,000 people and the annual rate of mortality being 171.2 per 100,000 men and women.

Looking at the global statistics, the World Health Organization states that the number of new cancer cases over the next two decades is anticipated to grow by 70.0%. In 2012, an estimated 14 million new cases of cancer were diagnosed and approximately 8.2 million people worldwide died from the disease. The most common causes of cancer-related deaths are cancers of the lung, liver, stomach, colon or rectum, and breast.

Get Sample Report:

Here’s a look at some of the major ongoing trends characterizing the global cancer supportive care products market:

  • Rapid progress in cancer treatment procedures has resulted in high levels of morbidity and toxicity among patients undergoing radiation therapy or chemotherapy. This increases the chances of induced side effects such as cancer pain, bone metastasis, induced neutropenia, oral mucositis, and induced anemia, vomiting, and nausea. This has resulted in increased demand for cancer supportive care products.

  • Rising incidence of different kinds of cancer has led to the growing demand for effective cancer supportive care products.

  • Increased effectiveness of anti-cancer drugs such as non-steroidal anti-inflammatory drugs, anti-emetics drugs, and opioid drugs also drives the growth of the cancer supportive care products market.

  • Rise in overall healthcare expenditure not just in developed countries but also in emerging economies boosts the affordability of cancer supportive care products.

  • Strong initiatives by the government to increase adherence and improve access to various quality drugs fuels the global market.

  • Effective direct-to-consumer marketing in countries such as the U.S. also supports the growth of the market.

  • Absence of post-treatment patient care in Eastern Europe presents lucrative opportunities for vendors of cancer supportive care products.

  • Expansion of pharmacists’ skill base and healthcare infrastructural facilities in emerging markets of Asia Pacific, Latin America, and the Middle East and Africa is anticipated to boost the cancer supportive care products market in the near future.

The key challenges, however, that the global market needs to be wary of are poor reimbursement policies, cost issues, and late diagnosis of cancer.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s